Literature DB >> 17472308

Core decompression and nonvascularized bone grafting for the treatment of early stage osteonecrosis of the femoral head.

Michael A Mont1, German A Marulanda, Thorsten M Seyler, Johannes F Plate, Ronald E Delanois.   

Abstract

Osteonecrosis of the femoral head is a devastating disease with many patients ultimately requiring a total hip arthroplasty. When the disease is diagnosed in its early stages (before collapse of the femoral head), various procedures such as core decompression (with and without bone grafting), osteotomies, as well as nonvascularized and vascularized bone grafting can be used in an effort to preserve the joint. The efficacy of core decompression has been peer-reviewed in more than 40 studies. In general, this treatment is most successful for patients with early stage, small- and medium-sized lesions, before collapse of the femoral head. Various methods of nonvascularized bone grafting have been used. Results have varied; however, a 60% to 80% success rate has been achieved at 5- to 10-year follow-up. In the future, these procedures may be used with various other biologic adjunctive growth and differentiation factors, which may lead to higher rates of successful treatment.

Entities:  

Mesh:

Year:  2007        PMID: 17472308

Source DB:  PubMed          Journal:  Instr Course Lect        ISSN: 0065-6895


  30 in total

1.  Clinical and radiological outcome of the treatment of osteonecrosis of the femoral head using the osteonecrosis intervention implant.

Authors:  Thilo Floerkemeier; Fritz Thorey; Dorothea Daentzer; Matthias Lerch; Phillip Klages; Henning Windhagen; Gabriela von Lewinski
Journal:  Int Orthop       Date:  2010-01-30       Impact factor: 3.075

2.  A modified porous tantalum implant technique for osteonecrosis of the femoral head: survivorship analysis and prognostic factors for radiographic progression and conversion to total hip arthroplasty.

Authors:  Yaosheng Liu; Xiuyun Su; Shiguo Zhou; Lei Wang; Cheng Wang; Shubin Liu
Journal:  Int J Clin Exp Med       Date:  2015-02-15

3.  A current review of non-vascularized bone grafting in osteonecrosis of the femoral head.

Authors:  Todd P Pierce; Randa K Elmallah; Julio J Jauregui; Shiva Poola; Michael A Mont; Ronald E Delanois
Journal:  Curr Rev Musculoskelet Med       Date:  2015-09

4.  3D-printed porous titanium changed femoral head repair growth patterns: osteogenesis and vascularisation in porous titanium.

Authors:  Wei Zhu; Yan Zhao; Qi Ma; Yingjie Wang; Zhihong Wu; Xisheng Weng
Journal:  J Mater Sci Mater Med       Date:  2017-03-01       Impact factor: 3.896

5.  Therapeutic effect of minimally invasive decompression combined with impaction bone grafting on osteonecrosis of the femoral head.

Authors:  Hong-Jun Zhang; You-Wen Liu; Zhi-Qian Du; Huili Guo; Ke-Jie Fan; Guo-Hui Liang; Xing-Cai Liu
Journal:  Eur J Orthop Surg Traumatol       Date:  2012-11-27

6.  What is the rate of patients undergoing a total hip arthroplasty after core decompression and insertion of a tantalum rod in osteonecrosis of the femoral head: a systematic review.

Authors:  Jean-Charles Aurégan; Benoît Villain; Thierry Bégué
Journal:  Int Orthop       Date:  2018-05-04       Impact factor: 3.075

7.  Vascular endothelial growth factor/bone morphogenetic protein-2 bone marrow combined modification of the mesenchymal stem cells to repair the avascular necrosis of the femoral head.

Authors:  Xiao-Wei Ma; Da-Ping Cui; De-Wei Zhao
Journal:  Int J Clin Exp Med       Date:  2015-09-15

8.  SAS weekly rounds: avascular necrosis.

Authors:  Thomas W Hamilton; Susan M Goodman; Mark Figgie
Journal:  HSS J       Date:  2009-03-18

Review 9.  Available Findings Fail to Provide Strong Evidence of the Role of Bone Morphogenic Protein-2 in Femoral Head Osteonecrosis.

Authors:  Ali Parsa; Hamed Vahedi; Karan Goswami; Arash Aalirezaie
Journal:  Arch Bone Jt Surg       Date:  2020-01

10.  Poor results of drilling in early stages of juxta-articular osteonecrosis in 12 joints affected by Gaucher disease.

Authors:  Ehud Lebel; Mici Phillips; Deborah Elstein; Ari Zimran; Menachem Itzchaki
Journal:  Acta Orthop       Date:  2009-04       Impact factor: 3.717

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.